National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a part of the United States Department of Health and Human Services and the National Institutes of Health (NIH). It is primarily focused on supporting research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases. The institute also disseminates information on a wide range of these conditions to the public and health professionals.
Overview[edit | edit source]
The NIAMS was established in 1986, following the Health Research Extension Act. Its mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases.
Research Areas[edit | edit source]
The institute's research efforts are broad and encompass various diseases and conditions, including but not limited to:
- Arthritis and rheumatic diseases
- Musculoskeletal diseases
- Bone diseases
- Muscle diseases
- Skin diseases
Research at NIAMS covers a wide spectrum from basic research at the molecular level to clinical trials and public health studies. The institute also supports research training and scientific conferences to foster knowledge exchange and collaboration among scientists.
Funding Opportunities[edit | edit source]
NIAMS offers funding opportunities for research in its areas of interest through grants and contracts to support the work of scientists in universities, hospitals, and other research institutions across the country. These opportunities are available for both basic and clinical research projects.
Public and Professional Education[edit | edit source]
In addition to its research activities, NIAMS provides a wealth of information to the public and health professionals on arthritis, musculoskeletal, and skin diseases. This includes educational materials, clinical guidelines, and resources for patients and their families.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
